ALS
Clinical trials for ALS explained in plain language.
Never miss a new study
Get alerted when new ALS trials appear
Sign up with your email to follow new studies for ALS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
ALS drug study halted early: did different dosing make a difference?
Disease control TerminatedThis study looked at two different dosing schedules of an oral medication called edaravone for people with ALS (Lou Gehrig's disease). The goal was to see if one schedule worked better at slowing the disease or delaying death. The study was stopped early, and involved 202 partici…
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated May 26, 2026 02:45 UTC
-
ALS drug trial halted: oral Edaravone's promise unfulfilled
Disease control TerminatedThis study tested an oral form of edaravone in 384 adults with ALS to see if it could slow the disease's progression over 48 weeks. Participants were randomly assigned to different dosing schedules. The trial was terminated early, and results are not yet available.
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
ALS patients rate telemedicine satisfaction in Short-Lived study
Knowledge-focused TerminatedThis study aimed to measure how satisfied people with ALS (Lou Gehrig's disease) who use a breathing machine at home were with video doctor visits. About 38 patients were planned to answer a satisfaction questionnaire. The study was stopped early, so results are limited, but the …
Matched conditions: ALS
Phase: NA • Sponsor: AGIR à Dom • Aim: Knowledge-focused
Last updated May 26, 2026 02:47 UTC